top of page

Téléphone : +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Afrezza Inhaler Device

Afrezza Inhaler Device

Manufacturer/Marketed By : CIPLA LTD

$1.05 $0.94

The Afrezza inhaler is a breath-powered device used to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is primarily prescribed for adults with type 1 or type...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

Active Pharmaceutical Ingredient

Afrezza Inhaler Device

SKU AFREZZA-INHALER-DEVICE
Prix d’origine

1,05 $US

Prix promotionnel

0,94 $US

The Afrezza inhaler is a breath-powered device used to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is primarily prescribed for adults with type 1 or type 2 diabetes who need rapid-acting insulin to control blood sugar levels after meals. The Afrezza Inhaler effectiveness lies in its fast absorption through the lungs, which helps reduce post-meal glucose spikes. Unlike injections, this device offers a needle-free option for insulin delivery. The Afrezza Inhaler Device does not contain insulin on its own. It works only with Afrezza insulin cartridges that contain dry powder human insulin. The inhaler itself is reusable, while the cartridges are single-use and available in different strengths. Afrezza Inhaler dosage is decided by the doctor based on meal size, blood sugar readings, and individual insulin needs. Many patients ask, Is Afrezza safe for teenagers, and its use in younger individuals should be determined strictly by a healthcare professional. As with any insulin therapy, users should be aware of possible Afrezza Inhaler side effects, such as cough, throat irritation, or low blood sugar. Before starting therapy, patients should receive proper training to ensure correct inhalation technique and safe use. Those considering treatment often enquire about the Afrezza Inhaler price, which may vary depending on availability and pharmacy. Always consult a healthcare provider to confirm suitability and correct usage before starting Afrezza therapy.

Active Pharmaceutical Ingredient

Uses

• Mealtime blood glucose control in adults with type 1 diabetes (used in combination with long-acting basal insulin).
• Mealtime blood glucose control in adults with type 2 diabetes who require insulin therapy.
• Reduction of postprandial (after-meal) blood sugar spikes.

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Common Side Effects:

Most Common Side Effects

• Bronchospasm
• Decline in lung function
• Severe hypoglycemia
• Allergic reactions

Common Side Effects

• Cough
• Throat irritation
• Hypoglycemia
• Headache

How To Use

To use the Afrezza Inhaler Device:

Safety Advice

• Pregnancy: Insulin therapy may be required during pregnancy, but the suitability of inhaled insulin should be assessed by a doctor.
• Breast Feeding: Limited data is available on the use of inhaled insulin during breastfeeding. Medical advice is recommended before use.
• Lungs: Afrezza is contraindicated in patients with chronic lung diseases such as asthma or COPD. Baseline and periodic lung function tests are required.
• Liver: Insulin requirements may vary in patients with liver impairment. Regular monitoring is advised.
• Alcohol: Alcohol can affect blood sugar control and increase the risk of hypoglycemia. Use with caution.
• Driving: Hypoglycemia can impair concentration and reaction time. Avoid driving if symptoms occur.

Disclaimer

Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.

Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.

Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.

Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.

bottom of page